{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:29:17Z","timestamp":1782826157799,"version":"3.54.5"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cystatin C (CysC) levels in amyotrophic lateral sclerosis (ALS) have been found changes, however, the associations between serum CysC levels and the progression and survival of ALS remain largely unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 1,086 ALS patients and 1,026 sex-age matched healthy controls (HCs) were enrolled in this study. Serum CysC, other renal function, and metabolic parameters were measured. Correlation analysis and binary logistic regression were used to explore the factors related to serum CysC. Kaplan\u2013Meier curve and Cox regression model were used for survival analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>CysC levels were significantly higher in ALS patients compared to HCs (0.94 vs. 0.85\u2009mg\/L, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). Compared with ALS patients with lower CysC levels, those with higher CysC levels had an older age of onset, significantly lower ALSFRS-R scores (40.1 vs. 41.3, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001), a faster disease progression rate (0.75 vs. 0.67, <jats:italic>p<\/jats:italic>\u2009=\u20090.011), and lower frontal lobe function scores (15.8 vs. 16.1, <jats:italic>p<\/jats:italic>\u2009=\u20090.020). In the correlation analysis, CysC levels were significantly negatively correlated with ALSFRS-R scores (<jats:italic>r<\/jats:italic>\u2009=\u2009\u22120.16, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). Additionally, ALS patients with higher CysC levels had significantly shorter survival time (40.0 vs. 51.8, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001) compared to patients with lower CysC levels. Higher CysC levels were associated with a higher risk of death in Cox analysis (HR: 1.204, 95% CI: 1.012\u20131.433). However, when treatment was included in the model, the result was no longer significant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>CysC levels in ALS patients were higher compared to HCs. Higher CysC levels were associated with greater disease severity, faster progression rate and shorter survival, needing early intervention.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2023.1309568","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T04:14:57Z","timestamp":1704428097000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Cystatin C is associated with poor survival in amyotrophic lateral sclerosis patients"],"prefix":"10.3389","volume":"17","author":[{"given":"Qirui","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianmi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwei","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"11282","DOI":"10.1016\/S0021-9258(18)67380-6","article-title":"Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids","volume":"261","author":"Abrahamson","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.semerg.2018.07.005","article-title":"Influence of age, gender, smoking, diabetes, thyroid and cardiac dysfunctions on cystatin C biomarker","volume":"45","author":"Al Musaimi","year":"2019","journal-title":"SEMERGEN"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0006-291X(84)91302-0","article-title":"The place of human \u03b3-trace (cystatin C) amongst the cysteine proteinase inhibitors","volume":"120","author":"Barrett","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ana.25276","article-title":"Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion","volume":"84","author":"Benatar","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1093\/brain\/awac394","article-title":"Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal","volume":"146","author":"Benatar","year":"2023","journal-title":"Brain J. Neurol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1056\/NEJMc1710379","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1212\/01.WNL.0000151980.42337.44","article-title":"Cystatin C as a risk factor for Alzheimer disease","volume":"64","author":"Cathcart","year":"2005","journal-title":"Neurology"},{"key":"ref9","first-page":"2957","article-title":"The expression features of serum cystatin C and homocysteine of Parkinson's disease with mild cognitive dysfunction","volume":"19","author":"Chen","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"790939","DOI":"10.3389\/fnagi.2021.790939","article-title":"Changes in serum cystatin C levels and the associations with cognitive function in Alzheimer's disease patients","volume":"13","author":"Chen","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jmedgenet-2021-107965","article-title":"Role of genetics in amyotrophic lateral sclerosis: a large cohort study in Chinese mainland population","volume":"59","author":"Chen","year":"2022","journal-title":"J. Med. Genet."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"153331752096510","DOI":"10.1177\/1533317520965101","article-title":"Effects of cystatin C on cognitive impairment in older Chinese adults","volume":"35","author":"Cui","year":"2020","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a frontal assessment battery at bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2741\/s170","article-title":"Protective mechanisms by cystatin C in neurodegenerative diseases","volume":"3","author":"Gauthier","year":"2011","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/clinchem\/35.1.179","article-title":"Cystatin C quantification in CSF","volume":"35","author":"George","year":"1989","journal-title":"Clin. Chem."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.7754\/Clin.Lab.2016.160807","article-title":"Clinical correlates and reference intervals for cystatin C in a Han population from Southeast China","volume":"63","author":"He","year":"2017","journal-title":"Clin. Lab."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1515\/CCLM.2007.504","article-title":"Sources of variation and reference intervals for serum cystatin C in a healthy Japanese adult population","volume":"45","author":"Ichihara","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s11255-023-03497-1","article-title":"Age-adjusted reference values and influencing factors of cystatin C in healthy Chinese population","volume":"55","author":"Ji","year":"2023","journal-title":"Int. Urol. Nephrol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00401-002-0667-9","article-title":"Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis","volume":"105","author":"Kikuchi","year":"2003","journal-title":"Acta Neuropathol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/neup.12105","article-title":"Bunina bodies in motor and non-motor neurons revisited: a pathological study of an ALS patient after long-term survival on a respirator","volume":"34","author":"Kimura","year":"2014","journal-title":"Neuropathology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/clinchem\/48.5.699","article-title":"Cystatin C: an improved estimator of glomerular filtration rate?","volume":"48","author":"Laterza","year":"2002","journal-title":"Clin. Chem."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1159\/000510219","article-title":"Cystatin C and risk of mild cognitive impairment: a systematic review and Meta-analysis","volume":"49","author":"Nair","year":"2020","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0304-3940(93)90576-7","article-title":"Bunina bodies in amyotrophic lateral sclerosis immunostained with rabbit anti-cystatin C serum","volume":"162","author":"Okamoto","year":"1993","journal-title":"Neurosci. Lett."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1440-1789.2007.00873.x","article-title":"Bunina bodies in amyotrophic lateral sclerosis","volume":"28","author":"Okamoto","year":"2008","journal-title":"Neuropathology"},{"key":"ref29","first-page":"5419","article-title":"Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"8","author":"Ren","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/mus.21683","article-title":"Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics","volume":"42","author":"Ryberg","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/ki.2010.431","article-title":"Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate","volume":"79","author":"Tangri","year":"2011","journal-title":"Kidney Int."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/ane.12134","article-title":"Utility of cystatin C for renal function in amyotrophic lateral sclerosis","volume":"128","author":"Tetsuka","year":"2013","journal-title":"Acta Neurol. Scand."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e1497","DOI":"10.1038\/cddis.2014.459","article-title":"Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity","volume":"5","author":"Watanabe","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/jnc.14285","article-title":"Intracerebroventricular administration of cystatin C ameliorates disease in SOD1-linked amyotrophic lateral sclerosis mice","volume":"145","author":"Watanabe","year":"2018","journal-title":"J. Neurochem."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/21678421.2014.966311","article-title":"Screening for cognitive impairment in a Chinese ALS population","volume":"16","author":"Wei","year":"2015","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s00415-014-7508-3","article-title":"Frontal lobe function and behavioral changes in amyotrophic lateral sclerosis: a study from Southwest China","volume":"261","author":"Wei","year":"2014","journal-title":"J. Neurol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e15133","DOI":"10.1371\/journal.pone.0015133","article-title":"Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis","volume":"5","author":"Wilson","year":"2010","journal-title":"PloS One"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.31083\/j.jin2002034","article-title":"On the correlation between serum cystatin C and Parkinson's disease in the Chinese population: a promising biomarker?","volume":"20","author":"Yang","year":"2021","journal-title":"J. Integr. Neurosci."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1111\/ene.15527","article-title":"Spatial-temporal pattern of propagation in amyotrophic lateral sclerosis and effect on survival: a cohort study","volume":"29","author":"Yang","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"663980","DOI":"10.3389\/fnins.2021.663980","article-title":"Serum cystatin C as a potential predictor of the severity of multiple system atrophy with predominant cerebellar Ataxia: a case-control study in Chinese population","volume":"15","author":"Ye","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00401-006-0141-1","article-title":"Amyotrophic lateral sclerosis with dementia: an autopsy case showing many Bunina bodies, tau-positive neuronal and astrocytic plaque-like pathologies, and pallido-nigral degeneration","volume":"112","author":"Yokota","year":"2006","journal-title":"Acta Neuropathol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1069837","DOI":"10.3389\/fnagi.2022.1069837","article-title":"Cystatin C predicts cognitive decline in multiple system atrophy: a 1-year prospective cohort study","volume":"14","author":"Zhang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-023-06957-9","article-title":"Serum cystatin C is a potential biomarker for predicting amyotrophic lateral sclerosis survival","author":"Zhu","year":"2023","journal-title":"Neurol. Sci."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.7150\/ijbs.25711","article-title":"Aberrant levels of cystatin C in amyotrophic lateral sclerosis: a systematic review and Meta analysis","volume":"14","author":"Zhu","year":"2018","journal-title":"Int. J. Biol. Sci."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1309568\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T04:15:02Z","timestamp":1704428102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1309568\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":44,"alternative-id":["10.3389\/fnins.2023.1309568"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1309568","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"article-number":"1309568"}}